Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients
Not Applicable
Active, not recruiting
- Conditions
- Gastric Cancer
- Interventions
- Device: mHealth App and wearable device
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 324
- Registration Number
- NCT04907591
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Seongbuk-gu, Korea, Republic of
The Prospective Non-randomized Case-control Study from Real-world Lung Cancer Patients
Recruiting
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: Immunnotherapy group
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1500
- Registration Number
- NCT04909164
- Locations
- 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Effects of Constraint-induced Movement Therapy With Home-based Hand-arm Bimanual Intensive Therapy in Children With Unilateral Cerebral Palsy
Not Applicable
Completed
- Conditions
- Cerebral Palsy, Spastic Hemiplegic
- Interventions
- Other: CIMTOther: H-HABIT
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT04904796
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Effect of tDCS on Motor Learning and Neural Network in Stroke Patients
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Device: Transcranial Direct Current StimulationBehavioral: Motor learning
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT04903457
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
Phase 4
Recruiting
- Conditions
- Acute Myocardial InfarctionHeart Failure
- Interventions
- Drug: SGLT2 inhibitorOther: Control
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT04899479
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Study to Evaluate Satisfaction of the Personal Health Record Platform for Chronic Patients in Emergency Department
Not Applicable
Completed
- Conditions
- Emergencies, Chronic Disease
- Interventions
- Other: Personal health wallet service for Chronic Patients in Emergency Department
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 57
- Registration Number
- NCT04883684
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Impact of Multi-Touch Functional Digital Game on Intelligence and Vitality for the Community-dwelling Elderly
Not Applicable
Completed
- Conditions
- Aging
- Interventions
- Behavioral: Functional digital game training groupBehavioral: Individual cognitive training
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT04873843
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Comparison of Hands-on Versus Online Learning About Ocular Ultrasound
Not Applicable
- Conditions
- Emergencies
- Interventions
- Other: online group
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT04834700
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Angio-IMR and Cardiac MR-derived MVO in STEMI Patients
Active, not recruiting
- Conditions
- ST-segment Elevation Myocardial Infarction (STEMI)
- Interventions
- Diagnostic Test: Cardiac magnetic resonance imaging
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 324
- Registration Number
- NCT04828681
- Locations
- 🇨🇳
Shanghai Institute of Cardiovascular Diseases, Shanghai, China, Shanghai, Shanghai, China
🇺🇸University of Iowa Carver College of Medicine, Iowa City, IA, USA, Iowa City, Iowa, United States
PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study
Phase 2
Recruiting
- Conditions
- Premenopausal HR+/HER2- Metastatic Breast Cancer
- Interventions
- Drug: Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib,Drug: Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib, Atezolizumab
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 178
- Registration Number
- NCT04819243
- Locations
- 🇰🇷
Samsung medical Center, Seoul, Gannam-gu, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath